TNF Pharmaceuticals, Inc. Cash Flow-to-Debt Ratio
TNF Pharmaceuticals, Inc. cash flow-to-debt ratio. TNF Pharmaceuticals, Inc. (TNFA) has a Cash Flow-to-Debt Ratio of -0.37x as of June 2025, meaning its operating cash flow of $-2.07 Million could theoretically repay 0% of its total liabilities ($5.55 Million) in one year. Check TNF Pharmaceuticals, Inc. (TNFA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of TNF Pharmaceuticals, Inc. (2004–2024)
Cash flow-to-debt ratio of TNF Pharmaceuticals, Inc. from 2004 to 2024. Historical debt coverage capacity for TNF Pharmaceuticals, Inc. across 21 annual periods. Check TNF Pharmaceuticals, Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
TNF Pharmaceuticals, Inc. Cash Flow-to-Debt Ratio by Year (2004–2024)
TNF Pharmaceuticals, Inc. cash flow-to-debt ratio by year from 2004 to 2024. Year-by-year debt coverage analysis for TNF Pharmaceuticals, Inc.. For the full cash flow conversion analysis, see TNF Pharmaceuticals, Inc. (TNFA) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.34x | $-8.98 Million | $6.70 Million | ▲ +47.5% |
| 2023 | -2.55x | $-12.98 Million | $5.09 Million | ▲ +40.9% |
| 2022 | -4.31x | $-12.27 Million | $2.84 Million | ▲ +74.2% |
| 2021 | -16.74x | $-19.52 Million | $1.17 Million | ▼ -712.5% |
| 2020 | -2.06x | $-4.66 Million | $2.26 Million | ▼ -2.5% |
| 2019 | -2.01x | $-3.07 Million | $1.53 Million | ▲ +53.4% |
| 2018 | -4.32x | $-8.52 Million | $1.97 Million | ▼ -51.6% |
| 2017 | -2.85x | $-5.08 Million | $1.79 Million | ▼ -15.8% |
| 2016 | -2.46x | $-4.17 Million | $1.70 Million | ▲ +20.1% |
| 2015 | -3.08x | $-5.13 Million | $1.67 Million | ▼ -46.0% |
| 2014 | -2.11x | $-3.88 Million | $1.84 Million | ▼ -50.7% |
| 2013 | -1.40x | $-2.73 Million | $1.95 Million | ▼ -183.7% |
| 2012 | -0.49x | $-1.04 Million | $2.11 Million | ▲ +84.4% |
| 2011 | -3.16x | $-2.26 Million | $714.78K | ▼ -132.6% |
| 2010 | -1.36x | $-1.73 Million | $1.27 Million | ▼ -13.1% |
| 2009 | -1.20x | $-1.38 Million | $1.15 Million | ▼ -355.3% |
| 2008 | 0.47x | $469.37K | $996.00K | ▲ +1839.7% |
| 2007 | 0.02x | $182.19K | $7.50 Million | ▲ +102.6% |
| 2006 | -0.94x | $-5.31 Million | $5.67 Million | ▲ +14.8% |
| 2005 | -1.10x | $-5.61 Million | $5.11 Million | ▼ -14.6% |
| 2004 | -0.96x | $-4.10 Million | $4.28 Million | — |